In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The price of Moderna Inc (NASDAQ: MRNA) closed at $33.76 in the last session, down -6.12% from day before closing price of $35.96. In other words, the price has decreased by -$6.12 from its previous closing price. On the day, 12.4 million shares were traded.
Ratios:
We take a closer look at MRNA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.62 and its Current Ratio is at 3.67. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.07.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Barclays on February 18, 2025, Downgraded its rating to Equal Weight and sets its target price to $45 from $111 previously.
On January 29, 2025, Goldman Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $99 to $51.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 03 ’25 when Bancel Stephane bought 160,314 shares for $31.22 per share. The transaction valued at 5,004,318 led to the insider holds 9,210,686 shares of the business.
SAGAN PAUL bought 31,620 shares of MRNA for $1,004,251 on Mar 03 ’25. The Director now owns 312,027 shares after completing the transaction at $31.76 per share. On Dec 09 ’24, another insider, Klinger Shannon Thyme, who serves as the Chief Legal Officer of the company, sold 529 shares for $44.68 each. As a result, the insider received 23,637 and left with 20,446 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 4.03 while its Price-to-Book (P/B) ratio in mrq is 1.20.
Stock Price History:
Over the past 52 weeks, MRNA has reached a high of $170.47, while it has fallen to a 52-week low of $29.25. The 50-Day Moving Average of the stock is -7.70%, while the 200-Day Moving Average is calculated to be -52.95%.
Shares Statistics:
A total of 386.00M shares are outstanding, with a floating share count of 341.55M. Insiders hold about 11.47% of the company’s shares, while institutions hold 70.76% stake in the company.
